These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 18329021)

  • 1. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice.
    Preyavichyapugdee N; Sahaphong S; Riengrojpitak S; Grams R; Viyanant V; Sobhon P
    Exp Parasitol; 2008 Jun; 119(2):229-37. PubMed ID: 18329021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette-Guérin producing the Schistosoma mansoni glutathione S-transferase.
    Kremer L; Riveau G; Baulard A; Capron A; Locht C
    J Immunol; 1996 Jun; 156(11):4309-17. PubMed ID: 8666802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine potential of recombinant cathepsin B against Fasciola gigantica.
    Chantree P; Phatsara M; Meemon K; Chaichanasak P; Changklungmoa N; Kueakhai P; Lorsuwannarat N; Sangpairoj K; Songkoomkrong S; Wanichanon C; Itagaki T; Sobhon P
    Exp Parasitol; 2013 Sep; 135(1):102-9. PubMed ID: 23811052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against Fasciola gigantica infection in mice by vaccination with recombinant juvenile-specific cathepsin L.
    Sansri V; Meemon K; Changklungmoa N; Kueakhai P; Chantree P; Chaichanasak P; Lorsuwannarat N; Itagaki T; Sobhon P
    Vaccine; 2015 Mar; 33(13):1596-601. PubMed ID: 25701317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine potential of recombinant saposin-like protein 2 against Fasciolosis gigantica in mice.
    Kueakhai P; Changklungmoa N; Riengrojpitak S; Chaichanasak P; Meemon K; Chaithirayanon K; Chantree P; Sansri V; Itagaki T; Sobhon P
    Vaccine; 2013 Nov; 31(47):5518-23. PubMed ID: 24075921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine potential of recombinant cathepsinL1G against Fasciola gigantica in mice.
    Changklungmoa N; Phoinok N; Yencham C; Sobhon P; Kueakhai P
    Vet Parasitol; 2016 Aug; 226():124-31. PubMed ID: 27514897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Fasciola hepatica recombinant 15-kDa fatty acid-binding protein T-cell epitopes that protect against experimental fascioliasis in rabbits and mice.
    Muro A; Casanueva P; López-Abán J; Ramajo V; Martínez-Fernández AR; Hillyer GV
    J Parasitol; 2007 Aug; 93(4):817-23. PubMed ID: 17918360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum antibody isotype responses of Fasciola-infected sheep and cattle to excretory and secretory products of Fasciola species.
    Phiri IK; Phiri AM; Harrison LJ
    Vet Parasitol; 2006 Nov; 141(3-4):234-42. PubMed ID: 16797844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overproduction of SM28GST in a baculovirus expression vector and its use to evaluate the in vivo immune responses of mice vaccinated against Schistosoma mansoni with naked DNA encoding the SM28GST gene.
    Kayes SG; Shaneyfelt RC; Monteiro C; O'Brien JJ
    J Parasitol; 1998 Aug; 84(4):764-70. PubMed ID: 9714208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of recombinant 2-Cys peroxiredoxin protein as a vaccine for Fasciola gigantica infection.
    Sangpairoj K; Apisawetakan S; Changklungmoa N; Kueakhai P; Chaichanasak P; Sobhon P; Chaithirayanon K
    Exp Parasitol; 2018 Nov; 194():16-23. PubMed ID: 30240576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R; Tallima H
    Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on heterologous resistance between schistosomiasis mansoni and fascioliasis.
    Hafez AH; Soliman MA; Hassounah OA; Raouf AA; Amir EM
    J Egypt Soc Parasitol; 2000 Aug; 30(2):413-21. PubMed ID: 10946503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology.
    Pinho JM; Cardoso FC; Lopes DO; Pinheiro CS; Caliari MV; Oliveira FM; Leite LC; Oliveira SC
    Parasitology; 2010 Jun; 137(7):1079-88. PubMed ID: 19835649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasciola gigantica: immunodiagnosis of fasciolosis by detection of circulating 28.5 kDa tegumental antigen.
    Anuracpreeda P; Wanichanon C; Chawengkirtikul R; Chaithirayanon K; Sobhon P
    Exp Parasitol; 2009 Dec; 123(4):334-40. PubMed ID: 19723524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasciola gigantica fatty acid binding protein (FABP) as a prophylactic agent against Schistosoma mansoni infection in CD1 mice.
    Rabia Aly I; Diab M; El-Amir AM; Hendawy M; Kadry S
    Korean J Parasitol; 2012 Mar; 50(1):37-43. PubMed ID: 22451732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and vaccine potential of Fasciola gigantica saposin-like protein 1 (SAP-1).
    Kueakhai P; Changklungmoa N; Waseewiwat P; Thanasinpaiboon T; Cheukamud W; Chaichanasak P; Sobhon P
    Vet Parasitol; 2017 Jan; 233():115-122. PubMed ID: 28043381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and partial characterization of an antigen shared between Schistosoma mansoni, Fasciola hepatica, and Biomphalaria glabrata.
    Rasmussen KR; Hillyer GV; Kemp WM
    J Parasitol; 1985 Dec; 71(6):792-8. PubMed ID: 2419536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of a monoclonal antibody against recombinant saposin-like protein 2 of Fasciola gigantica.
    Kueakhai P; Changklungmoa N; Chaithirayanon K; Songkoomkrong S; Riengrojpitak S; Sobhon P
    Acta Trop; 2013 Feb; 125(2):157-62. PubMed ID: 23164839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schistosoma mansoni hexokinase: cDNA cloning and immunogenicity studies.
    Shoemaker CB; Reynolds SR; Wei G; Tielens AG; Harn DA
    Exp Parasitol; 1995 Feb; 80(1):36-45. PubMed ID: 7821409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of Fasciola gigantica infection using a monoclonal antibody-based sandwich ELISA for detection of circulating cathepsin B3 protease.
    Anuracpreeda P; Chawengkirtikul R; Tinikul Y; Poljaroen J; Chotwiwatthanakun C; Sobhon P
    Acta Trop; 2013 Jul; 127(1):38-45. PubMed ID: 23567552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.